The chemicals in the Myco DDR reagents treat specimens to make the detection of TB easier and more reliable. The Myco DDR will be primarily marketed to the Western world initially, but IMMY is in the process of developing a version that will be less expensive and will be ideal for use in Third World countries.
The TB tests have expanded IMMY’s market and require more space for manufacturing.
When IMMY moved into its current location in the Norman Business park, the building was bigger than they needed at the time. The Bauman brothers were forward thinking and planned to grow into those new digs.
Now, the company has outgrown its current location, and the UNP business park has the space the growing company needs.
“We are looking at potentially 100 percent growth in the next year,” Scott Bauman said.
IMMY receives grants to facilitate the work it does with organizations like the CDC, but in many cases, IMMY is invited to participate in those grants because IMMY’s research is needed.
Breaking news, severe weather alerts, AMBER alerts, sports scores from The Norman Transcript are available as text messages right to your phone or mobile device. You decide which type of alerts you want to receive. Find out more or to signup, click here.